PAR DRUGS AND CHEM LTD Share Price

NSE: PAR

S Cap

₹ 163.37

-₹4.88 (-2.9%)

Last updated 03 Sep, 2026, 14:02 IST

PAR DRUGS AND CHEM LTD Share Price Today

As of 3 Sep 2026, PAR DRUGS AND CHEM LTD share price is ₹163.37. The stock opened at ₹175.00, compared to its previous close of ₹168.25. During today's trading session, PAR DRUGS AND CHEM LTD share price moved in the range of ₹155.10 to ₹180.00, with an average price of ₹167.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹78.05 and a high of ₹180.00. On the performance front, PAR DRUGS AND CHEM LTD share price has increased by 82.82% over the last six months and is up 66.87% on a year-on-year basis.

₹155.10

2.90% down today

₹180.00

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 73.27 % in last 1 month

PAR DRUGS AND CHEM LTD Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹8,33,010+₹3,33,010 (+66.60%)

3 Year

₹3,86,766-₹1,13,234 (-22.65%)

5 Year

₹3,88,144-₹1,11,856 (-22.37%)

₹151.43₹185.07

Circuit Low

Circuit High

₹78.05₹180.00

52-Week Low

52-Week High

Circuit

₹151.43

₹185.07

52-week

₹78.05

₹180.00

About PAR DRUGS AND CHEM LTD

ISIN

INE04LG01015

Sector Market Cap

₹ 207.03 Cr

Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.

PAR DRUGS AND CHEM LTD Financial Highlights

Revenue: PAR DRUGS AND CHEM LTD reported revenue of ₹107.66 crore in FY26 vs ₹103.12 crore in FY25. It showed an increase of 4.40% on a yearly basis.
Operating Profit: PAR DRUGS AND CHEM LTD reported an operating profit of ₹17.30 crore in FY26 vs ₹17.92 crore in FY25. It showed a decrease of 3.46% on a year-on-year basis.
Net Profit: PAR DRUGS AND CHEM LTD reported a net profit of ₹13.11 crore in FY26 vs ₹13.36 crore in FY25. It showed a decrease of 1.87% on a yearly basis.

PAR DRUGS AND CHEM LTD Quarterly Result Highlights

PAR DRUGS AND CHEM LTD reported revenue of ₹32.22 crore in Jun 2026, compared with ₹19.97 crore in Mar 2026, representing an increase of 61.34% on a quarter-on-quarter (QoQ) basis.
PAR DRUGS AND CHEM LTD reported an operating profit of ₹6.33 crore in Jun 2026, compared with ₹0.83 crore in Mar 2026, representing an increase of 662.65% on a quarter-on-quarter (QoQ) basis.
PAR DRUGS AND CHEM LTD reported a profit of ₹4.71 crore in Jun 2026, compared with ₹0.85 crore in Mar 2026, reflecting an increase of 454.12% on a QoQ basis.
The earnings per share (EPS) of PAR DRUGS AND CHEM LTD stood at ₹10.86 during Jun 2026.

Know more

Promoters

73.41%

FII

0.00%

Other DII

0.09%

Retail and other

26.51%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

207.03

P/E

14.28

P/B

1.85

ROE

11.71%

D/E

0.00

ROCE

15.56%

Div. Yield

0.00%

EPS(TTM)

10.65

Turnover

0.84

EV/EBITDA

5.69

Net Margin

0.00%

Op. Margin

0.00%

ROA

11.21%

Quick Ratio

0.00

Curr. Ratio

4.68

Mkt Cap Cr

207.03

P/E

14.28

P/B

1.85

ROE

11.71%

D/E

0.00

ROCE

15.56%

Div. Yield

0.00%

EPS(TTM)

10.65

Turnover

0.84

EV/EBITDA

5.69

Net Margin

0.00%

Op. Margin

0.00%

ROA

11.21%

Quick Ratio

0.00

Curr. Ratio

4.68

Based on fundamentals, this stock's

Performance

Excellent

Par Drugs & Che. outperforming all market indices

Valuation

Fairly Valued

Par Drugs & Che. appears to be fairly valued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,63,791.00	38.28	5.55	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,45,081.00	83.79	14.62	15.32%	0.00	19.56%	629.49	0.32%	0.55	98.19
Torrent Pharmaceuticals	1,90,351.00	88.29	22.64	25.49%	1.69	13.85%	222.76	0.68%	0.49	58.70
Zydus Lifesciences	1,14,833.00	25.00	4.24	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,14,163.00	34.02	3.32	11.27%	0.00	14.95%	423.36	0.92%	0.45	43.52
Laurus Labs	1,00,660.00	92.32	18.99	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Lupin	98,431.00	17.73	4.38	23.76%	0.04	24.88%	659.00	0.84%	0.57	129.18
Dr. Reddy's Laboratories	96,906.30	30.44	2.55	11.07%	0.18	12.54%	377.95	0.69%	0.41	38.68
Mankind Pharma	97,467.00	47.54	6.03	11.74%	0.34	13.13%	396.98	0.04%	0.44	49.37
Aurobindo Pharma	95,299.80	25.68	2.52	9.25%	0.19	11.76%	394.82	0.24%	0.38	41.58

PAR DRUGS AND CHEM LTD Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹100.97	₹95.64	₹95.75	₹75.07
Other Income	₹2.15	₹0.24	₹0.24	₹0.18
Total Revenue	₹103.12	₹95.88	₹95.99	₹75.26
Total Expenses	₹85.20	₹76.37	₹80.91	₹62.56
Profit Before Tax	₹17.92	₹19.52	₹15.08	₹12.70
Tax	₹4.57	₹5.02	₹3.75	₹3.49
Profit After Tax	₹13.36	₹14.50	₹11.33	₹9.21
EPS - Basic	₹10.86	₹11.78	₹9.21	₹7.49
EPS - Diluted	₹10.86	₹11.78	₹9.21	₹7.49

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹17.92	₹19.52	₹15.08	₹12.70
Income before WC changes	₹20.51	₹22.61	₹18.10	₹16.16
Change in Assets	-₹4.68	₹4.87	₹1.12	-₹7.58
Change in Liabilities	₹4.85	-₹2.87	-₹1.58	₹2.15
Change in WC	₹0.17	₹2.00	-₹0.46	-₹5.43
Cash flow from Operations	₹16.16	₹20.25	₹13.38	₹7.62
Cash flow from Investing	-₹25.24	-₹5.84	-₹7.34	-₹3.02
Cash flow from Financing	₹0.00	₹0.00	₹0.00	-₹9.55
Total Cash Flow	-₹9.08	₹14.41	₹6.04	-₹4.96
Cash (Start of the year)	₹36.65	₹22.24	₹16.21	₹21.16
Cash (End of the year)	₹27.58	₹36.65	₹22.24	₹16.21

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹64.53	₹41.99	₹39.43	₹35.13
Current Assets	₹54.86	₹59.62	₹49.44	₹43.56
Total Assets	₹119.39	₹101.61	₹88.87	₹78.69
Current Liabilities	₹16.57	₹12.44	₹13.99	₹14.86
Net Current Asset	₹38.29	₹47.18	₹35.45	₹28.71
Non-Current Liabilities	₹3.85	₹3.54	₹3.64	₹3.96
Equity Capital	₹98.97	₹85.63	₹71.24	₹59.88
Total Equity & Liabilities	₹119.39	₹101.61	₹88.87	₹78.69